EMPOWER T2n is a free education programme for people living with Type 2 diabetes. EMPOWER T2n is designed to help people understand what Type 2
Oxford-based Owen Mumford has launched Ateria SafeControl, its next generation of safety pen needles. Described as an active safety pen needle for healthcare professionals who
As reported by Zacks Equity Research in June 2021, Medtronic recently secured two back-to-back European regulatory approvals in the diabetes management space, the first for
With calls for the Body Mass Index (BMI) to be scrapped, one woman shares her experience of being refused treatment for an eating disorder because
People living with Type 2 diabetes are on average waiting more than two years before receiving a diagnosis. There are around 4.8m people living with
An online resource centre for Type 1 diabetes information in regional South-East Asian languages has been created. Hellotype1 is part of Action4Diabetes a UK-registered charity
Fear and uncertainty have been our constant companions since the outbreak of COVID-19. Dealing with this “new normal” is stressful, but for people with diabetes
Middle-aged men in England are being encouraged to take Diabetes UK’s ‘Know Your Risk’ quiz to test their vulnerability to Type 2 diabetes, as part of an
Dr Paul Weightman-Potter talks about his JDRF-funded research, growing brain cells in a dish and his personal reasons for working in Type 1 diabetes research.
The Obesity Health Alliance, a coalition of over 40 leading health organisations, medical royal colleges and campaign groups, following the total ban on online junk
